Evidence map›Paper›PMID 32362424›Full record

SynthesisMedicina intensiva

[Intensive care during the 2019-coronavirus epidemic].

A González-Castro, P Escudero-Acha, Y Peñasco, O Leizaola, V Martínez de Pinillos Sánchez, A García de Lorenzo

Abstract readSystematic Review
In one paragraph

Synthesis in Medicina intensiva. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A González-CastroServicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España. Electronic address: e409@humv.es.
P Escudero-AchaServicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España.
Y PeñascoServicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España.
O LeizaolaServicio de Medicina Intensiva, Hospital Universitario Central de Asturias, Oviedo, Asturias, España.
V Martínez de Pinillos SánchezComplejo Hospitalario de Jaén, Jaén, España.
A García de LorenzoServicio de Medicina Intensiva, Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On 31 December 2019, the Health Commission of Hubei Province of China first unveiled a group of unexplained cases of pneumonia, which WHO subsequently defined as the new coronavirus of 2019 (SARS-CoV-2). SARS-CoV-2 has presented rapid person-to-person transmission and is currently a global pandemic. In the largest number of cases described to date of hospitalized patients with SARS-CoV-2 disease (2019-nCoViD), 26% required care in an intensive care unit (ICU). This pandemic is causing an unprecedented mobilization of the scientific community, which has been associated with an exponentially growing number of publications in relation to it. This narrative literature review aims to gather the main contributions in the area of intensive care to date in relation to the epidemiology, clinic, diagnosis and management of 2019-nCoViD.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAge FactorsAngiotensin-Converting Enzyme 2Antiviral AgentsAsymptomatic InfectionsCOVID-19Critical CareCritical IllnessHumansPeptidyl-Dipeptidase APersonal Protective EquipmentSARS-CoV-2Standard of CareACE2 protein, humanAngiotensin-Converting Enzyme 2Antiviral AgentsPeptidyl-Dipeptidase AcoronavirusCoronavirusCuidados intensivosFactores de riesgoIntensive carePandemiaPandemicRisk factorsSARS-CoV-2TriageTriaje

Identifiers

PMID32362424
PMCPMC7342025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.